# EDGAR Filing Document

**Accession Number:** 0001909617
**File Stem:** 0001104659-26-022272
**Filing Date:** 2026-3
**Character Count:** 3574
**Document Hash:** 8c0ab54c14b3002f3767422840d97180
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-26-022272.hdr.sgml**: 20260302

**ACCESSION NUMBER**: 0001104659-26-022272

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20260302

**EFFECTIVENESS DATE**: 20260302

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Qiming U.S. Ventures Management, LLC
- **CENTRAL INDEX KEY:** 0001909617

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-22101
- **FILM NUMBER:** 26707935

**BUSINESS ADDRESS:**
- **STREET 1:** 11100 NE 8TH ST., SUITE 200
- **CITY:** BELLEVUE
- **STATE:** WA
- **ZIP:** 98004
- **BUSINESS PHONE:** (425) 709-0772

**MAIL ADDRESS:**
- **STREET 1:** 11100 NE 8TH ST., SUITE 200
- **CITY:** BELLEVUE
- **STATE:** WA
- **ZIP:** 98004

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001909617

**Date of Report:** 09/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** Qiming U.S. Ventures Management, LLC

**Address:** 11100 NE 8TH ST., SUITE 200, BELLEVUE, WA 98004

**Telephone number:** 425-709-0772

**Name of agent for service:** Ryan Baker

**Agent Address:** c/o Qiming U.S. Ventures Management, LLC, Bellevue, WA 98004

**Reporting Period:** Report for the year ended 09/30/2025

**SEC File Number:** 028-22101

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER            |     CUSIP | MEETING DATE   | VOTE DESCRIPTION                                                                   | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   | SHARES VOTED FOR OR AGAINST MANAGEMENT   | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|---:|:---|:---|:---|---:|---:|:---|:---|:---|:---|
| Jasper Therapeutics, Inc. | 471871202 | 07/03/2025     | Advisory vote on approval of the compensation of the named executive officers.     | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |
| Jasper Therapeutics, Inc. | 471871202 | 07/03/2025     | Advisory vote on the frequency of future advisory votes on executive compensation. | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |

## N-PX: Signature Block

**Reporting Person:** Qiming U.S. Ventures Management, LLC

**By (Signature):** Ryan Baker

**By (Printed Signature):** Ryan Baker

**By (Title):** Chief Financial Officer

**Date:** 03/02/2026